Tradestie Institutional Equity Comparison Engine

VCYT vs OPK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VCYT Overall Edge

VCYT Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Veracyte, Inc. (VCYT) driven by superior Valuation, Growth & Margin while OPK counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, VCYT trades at 15.3x Forward P/E with 15.0% operating margin (+15.1% YoY revenue) versus OPK at 53.8x Forward P/E and -27.8% operating margin (+15.9% YoY). In options structure, VCYT sits in BREAKDOWN (47th %ile IV; Dealer Gamma Walls on Pro) against OPK sits in CONSOLIDATION (3rd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VCYT
VCYT 15.3x vs OPK 53.8x Fwd P/E
Growth & Margin Winner VCYT
Op Margin 15.0% vs -27.8% ยท YoY +15.1% vs +15.9%
Momentum & Technical Winner OPK
1Y -39.8% vs +26.6% ยท 52W Pos 5% vs 73%
Options & Structure Winner OPK
BREAKDOWN (47th %ile IV) vs CONSOLIDATION (3rd %ile IV)
VCYT NASDAQ
Veracyte, Inc.
Services-Medical Laboratories
$24.01
-1.32% 1D
Market Cap $2.0B
1M Return -44.32%
1Y Return -39.78%
Forward P/E 15.3x
Unified AI Score
49.1 / 100 HOLD
Tech 55.0 Fund 56.0 Flow 57.0 Mom 55.0
OPK NASDAQ
Opko Health Inc.
Pharmaceutical Preparations
$1.62
-3.57% 1D
Market Cap $1.2B
1M Return +5.88%
1Y Return +26.56%
Forward P/E 53.8x
Unified AI Score
38.6 / 100 SELL
Tech 30.0 Fund 43.0 Flow 65.0 Mom 36.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VCYT -39.78% OPK +26.56% Spread: +66.34 pp (OPK Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period VCYT Revenue OPK Revenue VCYT Op. Margin OPK Op. Margin Margin Edge
FY2018 $90M $990M -24.2% -17.3% OPK
FY2019 $120M $900M -12.6% -30.4% VCYT
FY2020 $120M $1.44B -30.1% 4.0% OPK
FY2021 $220M $1.77B -37.3% 1.1% OPK
FY2022 $300M $1.00B -13.9% -22.5% VCYT
FY2023 $360M $860M -23.8% -18.2% OPK
FY2024 $450M $710M 3.6% -21.3% VCYT
FY2025 $520M $610M 11.2% -19.3% VCYT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VCYT (7) vs OPK (3)
Institutional Metric VCYT OPK Criterion Row Winner
Market Capitalization Scale $2.0B $1.2B Larger Scale VCYT
Trailing P/E Ratio Valuation 15.8x 53.8x Lower Multiple VCYT
Forward P/E Ratio Valuation 15.3x 53.8x Lower Multiple VCYT
Revenue Growth (YoY) Growth +15.1% +15.9% Higher Growth OPK
Operating Margin (TTM) Profitability 15.0% -27.8% Higher Margin VCYT
Net Profit Margin Profitability 21.8% -22.6% Higher Margin VCYT
Return on Equity (ROE) Capital Efficiency 9.4% -8.9% Higher ROE VCYT
52-Week Range Position Momentum 5% ($22โ€“$61) 73% ($1โ€“$2) Stronger Trend OPK
Beta / 30D Volatility Risk Regime 3.01ฮฒ ยท 199% Vol 0.77ฮฒ ยท 31% Vol Lower Realized Risk OPK
Unified Institutional Score Composite Signal 49.1 / 100 (HOLD) 38.6 / 100 (SELL) Higher Composite VCYT

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VCYT vs OPK Buy Guide
VCYT BREAKDOWN
99d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 47th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live VCYT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OPK CONSOLIDATION
78d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live OPK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VCYT nor OPK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.